Psychiatric disorders in women: Psychopharmacologic treatments

Journal of the American Pharmaceutical Association

Volumn 37, Issue 6, 1997, Pages 667-678

  Fankhauser, M P ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CLOMIPRAMINE; DESIPRAMINE; DIAZEPAM; FLUOXETINE; IMIPRAMINE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; NORTRIPTYLINE; OXAZEPAM; PRAZEPAM; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TEMAZEPAM; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

ANXIETY NEUROSIS; DEPRESSION; DRUG INDUCED DISEASE; FEMALE; HUMAN; MALE; MENOPAUSE; MENSTRUAL CYCLE; MENTAL DISEASE; POSTMENOPAUSE; PREGNANCY; PREVALENCE; PSYCHOPHARMACOLOGY; PSYCHOSIS; PUERPERIUM; REVIEW; SEX DIFFERENCE; UNITED STATES;

FEMALE; HUMANS; MALE; MENTAL DISORDERS; PREGNANCY; PREVALENCE; PSYCHOTROPIC DRUGS; SEX FACTORS; UNITED STATES;

EID: 0031265631     PISSN: 10865802     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1086-5802(16)30277-7     Document Type: Article

References (63)

1. National Institutes of Health, Office of Research on Women's Health. Report of the National Institutes of Health: Opportunities for Research on Women's Health. Washington, DC: U.S. Government Printing Office; 1992. NIH Publ No 92-3457.
2. D.L. Lourwood Treatment of chronic diseases during pregnancy Am Pharm NS35 6 1995 16 24
3. D.M. Jermain Treatment of postpartum depression Am Pharm NS35 1 1995 33 38
4. C. Baum D.L. Kennedy D.E. Knapp Prescription drug use in 1984 and changes over time Med Care. 26 1988 105 114
5. J.A. Hamilton B. Parry Sex-related differences in clinical drug responses: implications for women's health J Am Med Women Assoc. 38 1983 126 132
6. Hamilton JA, Grant M, Jensvold MF. Sex treatment of depressions: when does it matter? In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology of Women: Sex, Gender, and Hormonal Considerations. Washington, DC: American Psychiatric Press; 1996:241-57.
7. C. Domecq C.A. Naranjo I. Ruiz Sex-related variations in the frequency and characteristics of adverse drug reactions International Journal of Clinical Pharmacology, Therapy, and Toxicology. 18 1980 362 366
8. K.A. Yonkers J.A. Hamilton Sex differences in pharmacokinetics of psychotropic medications, part II: effects on selected psychotropics M.J. Jensvold U. Halbreich J.A. Hamilton Psychopharmacology of Women: Sex, Gender, and Hormonal Considerations 1996 American Psychiatric Press Washington, DC 43 71
9. R. Yassa D.V. Jeste Gender differences in tardive dyskinesia: a critical review of the literature Schizophr Bull. 18 1992 701 709
10. S.L. Dubovsky A. Giese Selected issues in the psychopharmacologic treatment of women with psychiatric disorders J Pract Psychiatry Behav Health. 3 1997 275 284
11. S.F. Greenfield Women and substance use disorders M.J. Jensvold U. Halbreich J.A. Hamilton Psychopharmacology of Women: Sex, Gender, and Hormonal Considerations 1996 American Psychiatric Press Washington, DC 299 321
12. S. Lindberg G. Agren Mortality among male and female hospitalized alcoholics in Stockholm 1962-1983 British Journal of Addiction. 83 1988 1193 1200
13. Louis Harris Associates The Commonwealth Fund Women's Survey 1993 The Commonwealth Fund New York
14. D.A. Regier J.H. Boyd J.D. Burke One month prevalence of mental disorders in the United States: based on five Epidemiologic Catchment Area sites Arch Gen Psychiatry. 45 1988 977 986
15. L.N. Robins B.Z. Locke D.A. Regier An overview of psychiatric disorders in America L.N. Robins D.A. Regier Psychiatric Disorders in America 1992 Free Press New York 328 366
16. P.P. Roy-Byrne Generalized anxiety and mixed anxiety-depression: association with disability and health care utilization J Clin Psychiatry 57 suppl 7 1996 86 91
17. J. Zajecka Importance of establishing the diagnosis of persistent anxiety Clin Psychiatry 58 suppl 3 1997 9 13
18. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 American Psychiatric Association Washington, DC
19. S.J. Blumenthal Improving women's mental and physical health: federal initiative and programs J.M. Oldham M.B. Riba American Psychiatric Press Review of Psychiatry Vol. 14 1995 American Psychiatric Press Washington, DC 181 204
20. R. Ross A. Frances T.A. Widiger Gender issues in DSM-IV J.M. Oldham M.B. Riba American Psychiatric Press Review of Psychiatry Vol. 14 1995 American Psychiatric Press Washington, DC 205 226
21. J.M. Oldham E. Hollander A.E. Skodol Impulsivity and Compulsivity 1996 American Psychiatric Press Washington, DC
22. J.A. Yaryura-Tobias F.A. Neziroglu Obsessive-Compulsive Disorder Spectrum: Pathogenesis, Diagnosis and Treatment 1997 American Psychiatric Press Washington, DC
23. M.F. Jensvold Nonpregnant reproductive-age women M.F. Jensvold U. Halbreich J.A. Hamilton Psychopharmacology and Women: Sex, Gender, and Hormonal Considerations 1996 American Psychiatric Press Washington, DC 139 161
24. S.J. Blumenthal Forging a Research Agenda 1990 National Women's Health Resource Center Washington, DC
25. K. Dawkins W. Potter Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on women Psychopharmacol Bull. 27 1991 412 426
26. K.A. Yonkers J.C. Kando J.O. Cole Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication Am J Psychiatry. 149 1992 587 595
27. W. Harrison M.A. Brumfield Psychopharmacological drug testing in women M.F. Jensvold U. Halbreich J.A. Hamilton Psychopharmacology of Women: Sex, Gender, and Hormonal Considerations 1996 American Psychiatric Press Washington, DC 371 391
28. S.I. Wolk M.M. Weissman Women and depression: an update J.M. Oldham M.B. Riba American Psychiatric Press Review of Psychiatry Vol. 14 1995 American Psychiatric Press Washington, DC 227 259
29. K.A. Yonkers J.A. Hamilton Psychotropic medications J.M. Oldham M.B. Riba American Psychiatric Press Review of Psychiatry Vol. 14 1995 American Psychiatric Press Washington, DC 307 332
30. G.M. Shenfield J.M. Griffin Clinical pharmacokinetics of contraceptive steroids: an update Clin Pharmacokinet. 20 1991 15 37
31. National Center for Health Statistics: Health United States 1991 and Prevention Profile. Hyattsville, Md: U.S. Public Health Service; 1992. DHHS Publ No PHS-92-1232.
32. R.C. Kessler K.A. McGonagle M. Swartz Sex and depression in the National Comorbidity Survey, I: lifetime prevalence, chronicity and recurrence J Affect Disord. 29 1993 85 96
33. R.C. Kessler K.A. McGonagle S. Zhao Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Study Arch Gen Psychiatry. 51 1994 8 19
34. Mood Disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association. 1994:317-91.
35. M.M. Weissman M.L. Bruce P.J. Leaf Affective disorders L.N. Robins D.A. Regier Psychiatric Disorders in America 1991 Free Press New York 53 80
36. K.L. Wisner S.B. Wheeler Prevention of recurrent postpartum major depression Hosp Community Psychiatry. 45 1994 1191 1196
37. Premenstrual Dysphoric Disorder. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association. 1994:715-8.
38. D.S. Janowsky U. Halbreich J. Rausch Association among ovarian hormones, other hormones, emotional disorders, and neurotransmitters M.F. Jensvold U. Halbreich J.A. Hamilton Psychopharmacology and Women: Sex, Gender, and Hormonal Considerations 1996 American Psychiatric Press Washington, DC 85 106
39. G. Perugi L. Musetti E. Simonini Gender-mediated clinical features of depressive illness: the importance of temperamental differences BrJ Psychiatry. 157 1990 835 841
40. G. Winokur W. Coryell M. Keller A prospective follow-up of patients with bipolar and primary unipolar affective disorders Arch Gen Psychiatry. 50 1993 457 465
41. C. Ernst J. Angst The Zurich study XII: sex difference in depression: evidence from longitudinal epidemiological data Eur Arch Psychiatry Clin Neurosci. 241 1992 222 230
42. R.C. Kessler R.L. Brown C.L. Broman Sex differences in psychiatric helpseeking: evidence from four large-scale surveys J Health Soc Behav. 22 1981 49 64
43. U. Halbreich Gonadal hormones and antihormones, serotonin and mood Psychopharmacol Bull. 26 1990 291 295
44. B.B. Sherwin Menopause, early aging, and elderly women M.F. Jensvold U. Halbreich J.A. Hamilton Psychopharmacology and Women: Sex, Gender, and Hormonal Considerations 1996 American Psychiatric Press Washington, DC 225 237
45. E.L. Klaiber Y. Kobayahi D.M. Broverman Plasma monoamine oxidase activity in regularly menstruating women and in amenorrheic women receiving cyclic treatment with estrogens and a progestin J Clin Endocrinol Metab. 33 1971 630 638
46. D.S. Charney H.L. Miller J. Licinio Treatment of depression A.F. Schatzberg C.B. Nemeroff The American Psychiatric Press Textbook of Psychopharmacology 1995 American Psychiatric Press Washington, DC 575 601
47. U. Halbreich H. Tworek Altered serotonergic activity in women with dysphoric premenstrual symptoms Int J Psychiatry Med. 23 1993 1 27
48. K.A. Yonkers W.A. Brown Pharmacologic treatments for premenstrual dysphoric disorder Psychiatric Annals. 26 1996 586 589
49. M.F. Jensvold K. Reed D.B. Jarrett Menstrual cycle-related depressive symptoms treated with variable antidepressant dosage Journal of Women's Health. 1 1992 109 115
50. Yonkers KA, Ellison JM. Anxiety disorders in women and their pharmacological treatment. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender and Hormonal Considerations. Washington, DC: American Psychiatric Press. 1996:261-85.
51. K.A. Yonkers Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? J Clin Psychiatry 58 suppl 3 1997 62 67
52. P.P. Roy-Byrne W. Katon Generalized anxiety disorder in primary care: the precursor/modifier pathway to increased health care utilization J Clin Psychiatry 58 suppl 3 1997 34 38
53. R.E. Hales D.A. Hilty M.G. Wise A treatment algorithm for the management of anxiety in primary care practice J Clin Psychiatry 58 suppl 3 1997 76 80
54. Eating Disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:539-50;729-31.
55. R.C. Casper Biology of eating disorders A.F. Schatzberg C.B. Nemeroff The American Psychiatric Press Textbook of Psychopharmacology 1995 American Psychiatric Press Washington, DC 557 572
56. W.S. Agras Treatment of eating disorders A.F. Schatzberg C.B. Nemeroff The American Psychiatric Press Textbook of Psychopharmacology 1995 American Psychiatric Press Washington, DC 725 734
57. U.S. General Accounting Office/National Institutes of Health. Problems in Implementing Policy on Women in Study Populations. Washington, DC: U.S. Government Printing Office. 1990. GAO/T-HRD-90-38.
58. E.L. Kinney J. Trautman J.A. Gold Underrepresentation of women in new drug trials: ramifications and remedies Ann Intern Med. 95 1981 495 499
59. U.S. Public Health Service, Office on Women's Health. PHS Action Plan for Women's Health. Washington, DC: U.S. Government Printing Office; 1991. DHHS Publ No PHS-91-50214.
60. U.S. Public Health Service, Office on Women's Health. PHS Action Plan for Women's Health 1991: Progress Review. Washington, DC: U.S. Government Printing Office; 1992. DHHS Publ No PHS-91-50215.
61. U.S. Food and Drug Administration. Guideline for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs. Rockville, Md: U.S. Government Printing Office; 1993. U.S. Food and Drug Administration Docket No. 93D-0236.
62. M.F. Jensvold J.A. Hamilton U. Halbreich Future research directions: methodological considerations for advancing gender-sensitive pharmacology M.F. Jensvold U. Halbreich J.A. Hamilton Psychopharmacology of Women: Sex, Gender, and Hormonal Considerations 1996 American Psychiatric Association Washington, DC 415 429
63. J.A. Hamilton K.A. Yonkers Sex differences in pharmacokinetics of psychotropic medications, part I: physiological basis of effects M.J. Jensvold U. Halbreich J.A. Hamilton Psychopharmacology of Women: Sex, Gender, and Hormonal Considerations 1996 American Psychiatric Press Washington, DC 11 42